

Natera (NTRA) banal surged Friday aft the institution reported what an expert called "blowout volume" for its cancer-detecting humor test, Signatera, successful the 2nd quarter. Signatera is simply a personalized humor trial that looks for microscopic pieces of tumor DNA successful the blood. Doctors tin usage it to surface for whether crab has returned pursuing treatment. During the 2nd quarter, 34,000…
Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Related news
Natera Eyes Massive New Cancer Market; In Buy Zone With Q2 Report Due
8/06/2026 Cancer trial supplier Natera is successful a bargain portion supra a cupful basal up of second-quarter results owed Thursday.
8/06/2026 Cancer trial supplier Natera is successful a bargain portion above...

2 weeks ago
20








English (CA) ·
English (US) ·
Spanish (MX) ·